Robert Davidson
Robert Davidson
Robert is Managing Editor of Applied Clinical Trials magazine. He received his B.S. degree in Magazine Journalism from the University of Maryland, College Park. Robert has significant experience in medical/scientific peer-review publishing, including a number of years with the IEEE Journals Department, where he managed 15 titles such as Transactions on Medical Imaging and Transactions on Nuclear Science. Earlier, he was an editorial researcher with National Magazine Award-winning IEEE Spectrum magazine. In 2003, he wrote a CME monograph covering COPD that was sponsored by GlaxoSmithKline. He has been with ACT for the past 3 years. In between his time with trade publications, Robert combined a personal interest and avocation as an editor with Field & Stream magazine, and he later gained public relations experience as a PR manager with Cendant Corporation.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
